47 research outputs found

    Investigations on the Reaction of C3 and C6 Ī±-Dicarbonyl Compounds with Hydroxytyrosol and Related Compounds under Competitive Conditions

    Get PDF
    Ī±-Dicarbonyl compounds are intermediates in reactions that lead to the formation of potentially harmful advanced glycation end-products. Carbonyl-trapping capacities of antiglycative substances have been traditionally limited to C2 and C3 Ī±-dicarbonyl structures. Glyoxal (GO)-, methylglyoxal (MGO)-, 3-deoxyglucosone (3-DG)-, 3-deoxygalactosone (3-DGal)-, 3,4-dideoxyglucoson-3-ene-, and glucosone-trapping capacities of hydroxytyrosol (HT), hydroxytyrosol acetate (HTA), and 3,4-dihydroxyphenylacetic acid (DOPAC) in simple (phenolic/dicarbonyl) and competitive model systems (phenolic/dicarbonyl/dicarbonyl) were investigated. HT and HTA were more effective for MGO than 3-DG and 3-DGal. Furthermore, DOPAC exerted higher trapping capacity than HT and HTA for C3 and C6 Ī±-dicarbonyl compounds. In the competitive systems, HT-related substances did not show preference for trapping 3-DG or 3-DGal and behaved as in the simple systems. In the presence of MGO, however, HT-related substances were more effective for trapping MGO than C6 structures. The results demonstrate the C6 Ī±-dicarbonyl-trapping capacities of HT, HTA, and DOPAC, with DOPAC exerting the highest activity.Peer Reviewe

    Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance

    Get PDF
    Glyoxal and methylglyoxal are reactive dicarbonyl metabolites formed and metabolized in physiological systems. Increased exposure to these dicarbonyls is linked to mutagenesis and cytotoxicity and enhanced dicarbonyl metabolism by overexpression of glyoxalase 1 is linked to tumour multidrug resistance in cancer chemotherapy. We report herein that glycation of DNA by glyoxal and methylglyoxal produces a quantitatively important class of nucleotide adduct in physiological systemsā€”imidazopurinones. The adduct derived from methylglyoxal-3-(2ā€²-deoxyribosyl)-6,7-dihydro-6,7-dihydroxy-6/7-methylimidazo-[2,3-b]purine-9(8)one isomersā€”was the major quantitative adduct detected in mononuclear leukocytes in vivo and tumour cell lines in vitro. It was linked to frequency of DNA strand breaks and increased markedly during apoptosis induced by a cell permeable glyoxalase 1 inhibitor. Unexpectedly, the DNA content of methylglyoxal-derived imidazopurinone and oxidative marker 7,8-dihydro-8-oxo-2ā€²-deoxyguanosine were increased moderately in glyoxalase 1-linked multidrug resistant tumour cell lines. Together these findings suggest that imidazopurinones are a major type of endogenous DNA damage and glyoxalase 1 overexpression in tumour cells strives to counter increased imidazopurinone formation in tumour cells likely linked to their high glycolytic activity

    Protective role of vitamin B6 (PLP) against DNA damage in Drosophila models of type 2 diabetes

    Get PDF
    Growing evidence shows that improper intake of vitamin B6 increases cancer risk and several studies indicate that diabetic patients have a higher risk of developing tumors. We previously demonstrated that in Drosophila the deficiency of Pyridoxal 5' phosphate (PLP), the active form of vitamin B6, causes chromosome aberrations (CABs), one of cancer prerequisites, and increases hemolymph glucose content. Starting from these data we asked if it was possible to provide a link between the aforementioned studies. Thus, we tested the effect of low PLP levels on DNA integrity in diabetic cells. To this aim we generated two Drosophila models of type 2 diabetes, the first by impairing insulin signaling and the second by rearing flies in high sugar diet. We showed that glucose treatment induced CABs in diabetic individuals but not in controls. More interestingly, PLP deficiency caused high frequencies of CABs in both diabetic models demonstrating that hyperglycemia, combined to reduced PLP level, impairs DNA integrity. PLP-depleted diabetic cells accumulated Advanced Glycation End products (AGEs) that largely contribute to CABs as Ī±-lipoic acid, an AGE inhibitor, rescued not only AGEs but also CABs. These data, extrapolated to humans, indicate that low PLP levels, impacting on DNA integrity, may be considered one of the possible links between diabetes and cancer

    Facile preparation of multifunctional superparamagnetic PHBV microspheres containing SPIONs for biomedical applications

    Get PDF
    The promising potential of magnetic polymer microspheres in various biomedical applications has been frequently reported. However, the surface hydrophilicity of superparamagnetic iron oxide nanoparticles (SPIONs) usually leads to poor or even failed encapsulation of SPIONs in hydrophobic polymer microspheres using the emulsion method. In this study, the stability of SPIONs in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) solution was significantly increased after surface modification with lauric acid. As a result, magnetic PHBV microspheres with high encapsulation efficiencies (71.0-87.4%) were prepared using emulsion-solvent extraction/evaporation method. Magnetic resonance imaging (MRI) showed significant contrast for the magnetic PHBV microspheres. The toxicity of these magnetic PHBV microspheres towards human T-lymphoma suspension cells and adherent colon carcinoma HT-29 cells was investigated using flow cytometry, and they were shown to be non-toxic in a broad concentration range. A model drug, tetracycline hydrochloride, was used to demonstrate the drug delivery capability and to investigate the drug release behavior of the magnetic PHBV microspheres. The drug was successfully loaded into the microspheres using lauric acid-coated SPIONs as drug carrier, and was released from the microspheres in a diffusion controlled manner. The developed magnetic PHBV microspheres are promising candidates for biomedical applications such as targeted drug delivery and MRI

    MALDI-TOF MS Characterization of Glycation Products of Whey Proteins in Glucose/Galactose Model System and Lactose-free Milk

    No full text
    The major modifications induced by thermal treatment of whey proteins R-lactalbumin (R-La) and Ī²-lactoglobulin (Ī²-Lg) in a model system mimicking lactose-free milk (L- sugar mix) were investigated by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS). The analysis of the intact R-La revealed species with up to 7 and 14 adducts from lactose and sugar mix, respectively, whereas for Ī²-Lg 3 and up to 5 sugar moieties were observed in the case of lactose and sugar mix experiments, respectively. A partial enzymatic hydrolysis with endoproteinase AspN prior to mass spectrometric analysis allowed the detection of further modifications and their localization in the amino acid sequence. Using R-cyano-4-chlorocinnamic acid as MALDI matrix, it could be shown that heating R-La and Ī²-Lg with glucose or galactose led to the modification of lysine residues that are not glycated by lactose. The higher glycation degree of whey proteins in a lactose-free milk system relative to normal milk with lactose reflects the higher reactivity of monosaccharides compared to the parent disaccharide. Finally, the analysis of the whey extract of a commercial lactose-free milk sample revealed that the two whey proteins were present as three main forms (native, single, and double hexose adducts)

    Small sized microplastics and pigmented particles in bottled mineral water

    No full text
    Up to now, only a few studies about microparticle contamination of bottled mineral water have been published. The smallest analysed particle size was 5 amp; 8239; amp; 956;m. However, due to toxicological reasons, especially microparticles smaller than 1.5 amp; 8239; amp; 956;m are critically discussed. Therefore, in the present study, 32 samples of bottled mineral water were investigated for contamination by microplastics, pigment and additive particles. Due to the application of aluminium coated polycarbonate membrane filters and micro Raman spectroscopy, a lowest analysed particle size of 1 amp; 8239; amp; 956;m was achieved. Microplastics were found in water from all bottle types in single use and reusable bottles made of poly ethylene terephthalate PET as well as in glass bottles. The amount of microplastics in mineral water varied from 2649 amp; 8239; amp; 8239;2857 per litre in single use PET bottles up to 6292 amp; 8239; amp; 8239;10521 per litre in glass bottles. While in plastic bottles, the predominant polymer type was PET; in glass bottles various polymers such as polyethylene or styrene butadiene copolymer were found. Hence, besides the packaging itself, other contamination sources have to be considered. Pigment particles were detected in high amounts in reusable, paper labelled bottles 195047 amp; 8239; amp; 8239;330810 pigment particles per litre in glass and 23594 amp; 8239; amp; 8239;25518 pigment particles per litre in reusable paper labelled PET bottles . Pigment types found in water samples were the same as used for label printing, indicating the bottle cleaning process as possible contamination route. Furthermore, on average 708 amp; 8239; amp; 8239;1024 particles per litre of the additive Tris 2,4 di tert butylphenyl phosphite were found in reusable PET bottles. This additive might be leached out from the bottle material itself. Over 90 of the detected microplastics and pigment particles were smaller than 5 amp; 8239; amp; 956;m and thus not covered by previous studies. In summary, this is the first study reporting about microplastics, pigment and additive particles found in bottled mineral water samples with a smallest analysed particle size of 1 amp; 8239; amp; 956;

    Influence of the production technology on kefir characteristics: Evaluation of microbiological aspects and profiling of phosphopeptides by LC-ESI-QTOF-MS/MS

    No full text
    The influence of production technology, namely, temperature, pH and 2-step fermentation (back-slopping approach), on the microbiological characteristics and on the phosphopeptide profile of kefir obtained with kefir grains was investigated. The growth of yeasts, lactic acid bacteria (LAB) and acetic acetic bacteria (AAB) in both grains and kefir was affected by the incubation temperature and by the use of back-slopping. In particular, at 25 Ā°C the microbiota of kefir grains was mainly composed by LAB and yeasts, while at 18 Ā°C yeasts represented the dominant group in kefir. Back-slopping at 25 Ā°C determined a significant increase of AAB. A comprehensive characterization of potentially bioactive peptides, including caseino-phosphopeptides (CPPs), was performed, for the first time, in kefir obtained with kefir grains, using preliminary enrichment on hydroxyapatite followed by dephosphorylation and analysis by Liquid Chromatography-ElectroSpray Ionization-Quadrupole-Time of Flight-tandem mass spectrometry (LC-ESI-QTOF-MS/MS). As a result, seventy-three phosphopeptides, mostly arising from caseins (79% Ī²-casein, 8% Ī±s1-casein and 9% Ī±s2-casein) and all including from three to five serine residues in their sequences, were identified. Seventy-one of them showed the typical motif ā€œSerP-SerP-SerP-Glu-Gluā€, which is crucial for the ability of caseins to bind to minerals. Several peptides were observed, for the first time, from the 1ā€“40 region of Ī²-casein. As for the effect of production technology, phosphopeptide profiles of kefirs obtained at 25 Ā°C and 18 Ā°C were very similar, whereas kefir produced under acidic conditions showed a predominance of smaller peptides, suggesting a higher level of proteolysis. Conversely, kefir obtained through back-slopping at 25 Ā°C contained longer peptides, thus indicating a lower proteolytic activity and a poor reproducibility in the kefir phosphopeptide profile occurring when grains are reused
    corecore